Literature DB >> 33026503

Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.

Jae Seok Bae1,2, Dong Ho Lee3,4, Jeongin Yoo1,2, Nam-Joon Yi5, Kwang-Woong Lee5, Kyung-Suk Suh5, Haeryoung Kim6, Kyung Bun Lee6.   

Abstract

OBJECTIVES: Post-hepatectomy liver failure (PHLF) can occur as a major complication after hepatic resection (HR) in patients with hepatocellular carcinoma (HCC) and negatively affects the prognosis. We aimed to retrospectively assess whether the spleen volume (SV) measured from preoperative CT images would be associated with the development of PHLF and overall survival (OS) after HR in patients with HCC.
METHODS: We enrolled 317 consecutive patients with very early/early stage HCC who underwent a preoperative CT and HR between January 2010 and December 2016. The SV was obtained from preoperative CT images using semi-automated volumetric software and was divided by body surface area to yield SVBSA. Receiver operating characteristic (ROC) curves and logistic regression analyses were performed to identify factors affecting the development of PHLF. The Cox proportional hazard model was used to identify prognostic factors for OS.
RESULTS: PHLF was observed in 72 patients (22.7% [72/317]). SVBSA was associated with the development of PHLF (odds ratio, 2.321; 95% CI, 1.347-4.001; p = 0.002) with the area under the ROC curve of 0.663 using the cutoff value of 107.5 cm3 (p < 0.001). SVBSA was also an influencing factor for OS (hazard ratio, 3.935; 95% CI 1.520-10.184; p = 0.005), with the optimal cutoff of 146 cm3. The 5-year OS rate was higher in 245 patients with a SVBSA ≤ 146 cm3 than in 72 patients with a SVBSA > 146 cm3 (95.0% vs. 78.7%, p < 0.001).
CONCLUSIONS: In patients with HCC, a larger SVBSA was associated with a higher rate of PHLF and worse OS after HR. The SVBSA may be useful in selecting good surgical candidates. KEY POINTS: • A significantly higher spleen volume divided by body surface area was observed in patients who experienced post-hepatectomy liver failure than in patients who did not (148 cm3 vs. 112 cm3, p < 0.001). • The area under the receiver operating characteristic curve of spleen volume divided by body surface area to predict the development of post-hepatectomy liver failure was 0.663 (p < 0.001). • Spleen volume divided by body surface area was a significant influencing factor for overall survival (hazard ratio, 3.935; 95% CI, 1.520-10.184; p < 0.001), with the optimal cutoff of 146 cm3.

Entities:  

Keywords:  Carcinoma, hepatocellular; Hepatectomy; Liver failure; Prognosis; Spleen

Mesh:

Year:  2020        PMID: 33026503     DOI: 10.1007/s00330-020-07313-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  49 in total

Review 1.  Results of liver transplantation: with or without Milan criteria?

Authors:  Vincenzo Mazzaferro
Journal:  Liver Transpl       Date:  2007-11       Impact factor: 5.799

Review 2.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

3.  Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.

Authors:  Hao Hu; Hong Han; Xi Kun Han; Wen Ping Wang; Hong Ding
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

4.  Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.

Authors:  Dorothea Theilig; Ingo Steffen; Maciej Malinowski; Martin Stockmann; Daniel Seehofer; Johann Pratschke; Bernd Hamm; Timm Denecke; Dominik Geisel
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

5.  Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma.

Authors:  Matteo Cescon; Antonio Colecchia; Alessandro Cucchetti; Eugenia Peri; Luciana Montrone; Giorgio Ercolani; Davide Festi; Antonio Daniele Pinna
Journal:  Ann Surg       Date:  2012-11       Impact factor: 12.969

Review 6.  Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

Authors:  Angelo Gatta; Massimo Bolognesi; Carlo Merkel
Journal:  Mol Aspects Med       Date:  2007-10-24

Review 7.  Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

8.  One thousand fifty-six hepatectomies without mortality in 8 years.

Authors:  Hiroshi Imamura; Yasuji Seyama; Norihiro Kokudo; Atsushi Maema; Yasuhiko Sugawara; Keiji Sano; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2003-11

Review 9.  Liver failure after major hepatic resection.

Authors:  Giuseppe Garcea; G J Maddern
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-26

10.  Post-hepatectomy liver failure after major hepatic surgery: not only size matters.

Authors:  Ulrika Asenbaum; Klaus Kaczirek; Ahmed Ba-Ssalamah; Helmut Ringl; Christoph Schwarz; Fredrik Waneck; Fabian Fitschek; Christian Loewe; Richard Nolz
Journal:  Eur Radiol       Date:  2018-05-16       Impact factor: 5.315

View more
  6 in total

1.  Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy.

Authors:  Tongdi Fang; Guo Long; Xingyu Mi; Wenxin Su; Lei Mo; Ledu Zhou
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

2.  Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Authors:  Lukas Müller; Felix Hahn; Aline Mähringer-Kunz; Fabian Stoehr; Simon Johannes Gairing; Friedrich Foerster; Arndt Weinmann; Peter Robert Galle; Jens Mittler; Daniel Pinto Dos Santos; Michael Bernhard Pitton; Christoph Düber; Uli Fehrenbach; Timo Alexander Auer; Bernhard Gebauer; Roman Kloeckner
Journal:  United European Gastroenterol J       Date:  2021-12-16       Impact factor: 4.623

3.  Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy.

Authors:  Lukas Müller; Simon Johannes Gairing; Roman Kloeckner; Friedrich Foerster; Arndt Weinmann; Jens Mittler; Fabian Stoehr; Tilman Emrich; Christoph Düber; Peter Robert Galle; Felix Hahn
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

4.  Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.

Authors:  Lukas Müller; Roman Kloeckner; Aline Mähringer-Kunz; Fabian Stoehr; Christoph Düber; Gordon Arnhold; Simon Johannes Gairing; Friedrich Foerster; Arndt Weinmann; Peter Robert Galle; Jens Mittler; Daniel Pinto Dos Santos; Felix Hahn
Journal:  Eur Radiol       Date:  2022-04-08       Impact factor: 7.034

5.  Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization.

Authors:  Hai-Tao Dai; Bin Chen; Ke-Yu Tang; Gui-Yuan Zhang; Chun-Yong Wen; Xian-Hong Xiang; Jian-Yong Yang; Yan Guo; Run Lin; Yong-Hui Huang
Journal:  J Gastrointest Oncol       Date:  2021-06

6.  Association between cellular immune response and spleen weight in mice with hepatocellular carcinoma.

Authors:  Wei Jiang; Yu Li; Shuqun Zhang; Guangyao Kong; Zongfang Li
Journal:  Oncol Lett       Date:  2021-06-30       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.